Clinical Trial Update: A Phase 3 Study to Evaluate Xilonix as an Anticancer Therapy in Patients With Symptomatic Colorectal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Xilonix for symptomatic/advanced colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Xilonix

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Symptomatic Colorectal Cancer, Advanced Colorectal Cancer | Phase 3 | Status: COMPLETED